BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30035383)

  • 1. Ventricular wall stress and silent myocardial damage are associated with pulse pressure in the general population.
    Takahashi T; Shishido T; Watanabe K; Sugai T; Toshima T; Kinoshita D; Yokoyama M; Tamura H; Nishiyama S; Takahashi H; Arimoto T; Miyamoto T; Watanabe T; Shibata Y; Konta T; Ueno Y; Kato T; Kayama T; Kubota I; Watanabe M
    J Clin Hypertens (Greenwich); 2018 Sep; 20(9):1319-1326. PubMed ID: 30035383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
    Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
    J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of heart-type fatty acid-binding protein with cardiovascular risk factors and all-cause mortality in the general population: the Takahata study.
    Otaki Y; Watanabe T; Takahashi H; Hirayama A; Narumi T; Kadowaki S; Honda Y; Arimoto T; Shishido T; Miyamoto T; Konta T; Shibata Y; Fukao A; Daimon M; Ueno Y; Kato T; Kayama T; Kubota I
    PLoS One; 2014; 9(5):e94834. PubMed ID: 24847804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of insulin resistance on silent and ongoing myocardial damage in normal subjects: the Takahata study.
    Narumi T; Shishido T; Kiribayashi N; Kadowaki S; Nishiyama S; Takahashi H; Arimoto T; Miyashita T; Miyamoto T; Watanabe T; Shibata Y; Konta T; Ueno Y; Kato T; Kayama T; Kubota I
    Exp Diabetes Res; 2012; 2012():815098. PubMed ID: 23093954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of heart-type fatty acid binding protein and brain natriuretic peptide can reliably risk stratify patients hospitalized for chronic heart failure.
    Niizeki T; Takeishi Y; Arimoto T; Takahashi T; Okuyama H; Takabatake N; Nozaki N; Hirono O; Tsunoda Y; Shishido T; Takahashi H; Koyama Y; Fukao A; Kubota I
    Circ J; 2005 Aug; 69(8):922-7. PubMed ID: 16041160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic value of heart-type fatty acid-binding protein combined with echocardiography in sepsis with cardiac insufficiency].
    Ding R; Cheng Q; Tian P; Guli B; Xu C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):478-482. PubMed ID: 32527357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of ventricular-arterial coupling and B-type natriuretic peptide in patients after myocardial infarction: a five-year follow-up study.
    Antonini-Canterin F; Enache R; Popescu BA; Popescu AC; Ginghina C; Leiballi E; Piazza R; Pavan D; Rubin D; Cappelletti P; Nicolosi GL
    J Am Soc Echocardiogr; 2009 Nov; 22(11):1239-45. PubMed ID: 19783121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
    Niizeki T; Takeishi Y; Arimoto T; Takabatake N; Nozaki N; Hirono O; Watanabe T; Nitobe J; Harada M; Suzuki S; Koyama Y; Kitahara T; Sasaki T; Kubota I
    J Card Fail; 2007 Mar; 13(2):120-7. PubMed ID: 17395052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cord Blood Biomarkers of Cardiac Dysfunction and Damage in Term Growth-Restricted Fetuses Classified by Severity Criteria.
    Perez-Cruz M; Crispi F; Fernández MT; Parra JA; Valls A; Gomez Roig MD; Gratacós E
    Fetal Diagn Ther; 2018; 44(4):271-276. PubMed ID: 29190628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic ability of B-type natriuretic peptide and impedance cardiography: testing to identify left ventricular dysfunction in hypertensive patients.
    Bhalla V; Isakson S; Bhalla MA; Lin JP; Clopton P; Gardetto N; Maisel AS
    Am J Hypertens; 2005 Feb; 18(2 Pt 2):73S-81S. PubMed ID: 15752936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction.
    Sarullo FM; Gristina T; Brusca I; Serio G; Taormina A; La Chiusa SM; Castello A; Borruso E; Paterna S; Di Pasquale P
    Minerva Cardioangiol; 2007 Apr; 55(2):149-55. PubMed ID: 17342035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in self-monitored pulse pressure correlate with improvements in B-type natriuretic Peptide and urinary albumin in treated hypertensive patients.
    Eguchi K; Matsui Y; Shibasaki S; Ishikawa J; Hoshide S; Ishikawa S; Kabutoya T; Schwartz JE; Pickering TG; Shimada K; Kario K;
    Am J Hypertens; 2007 Dec; 20(12):1268-75. PubMed ID: 18047916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy.
    Vanderheyden M; Goethals M; Verstreken S; De Bruyne B; Muller K; Van Schuerbeeck E; Bartunek J
    J Am Coll Cardiol; 2004 Dec; 44(12):2349-54. PubMed ID: 15607397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic determinants of myocardial B-type natriuretic peptide release: relative contributions of systolic and diastolic wall stress.
    Maeder MT; Mariani JA; Kaye DM
    Hypertension; 2010 Oct; 56(4):682-9. PubMed ID: 20713912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the primary prevention of cardiovascular events by using biomarkers to identify individuals with silent heart disease.
    Nadir MA; Rekhraj S; Wei L; Lim TK; Davidson J; MacDonald TM; Lang CC; Dow E; Struthers AD
    J Am Coll Cardiol; 2012 Sep; 60(11):960-8. PubMed ID: 22921971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships of Blood Pressure Circadian Rhythm and Brain Natriuretic Peptide with Left Ventricular Hypertrophy in the Patients with Primary Hypertension.
    Kou HJ; Wang X; Gao DF; Dong X; Wei J; Ma R
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):514-521. PubMed ID: 27825406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
    Suzuki S; Sugiyama S
    Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum levels of fatty acid-binding protein and brain natriuretic peptide in children with pneumonia complicated by acute congestive heart failure].
    Wang WD; Sun YP; Cui XQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):304-6. PubMed ID: 18554454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain Natriuretic Peptide and Particular Left Ventricle Segment Asynergy Associated with Cardioembolic Stroke from Old Myocardial Infarction.
    Hosomi N; Yoshimoto T; Kanaya Y; Neshige S; Hara N; Himeno T; Kono R; Takeshima S; Takamatsu K; Ota T; Miyamoto Y; Yasuda K; Shimoe Y; Ota T; Kuriyama M; Matsumoto M
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1165-1171. PubMed ID: 26922130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.